EP3154594
FAP-virkjuð efni til lækninga og notkun þeim tengd
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.6.2015EP published:
19.7.2023EP application number:
15807049.0
EP translation filed:
8.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
14.6.2035Expiry date:
14.6.2026Next due date:
30.6.2026
Title in English:
FAP-ACTIVATED THERAPEUTIC AGENTS, AND USES RELATED THERETOLanguage of the patent:
English
Timeline
Today
15.6.2015EP application
19.7.2023EP Publication
8.8.2023Translation submitted
15.9.2023Registration published
14.6.2026Expires
Owner
Name:
Bach Biosciences, LLCAddress:
31 Echo Landing, Moultonborough, NH 03254, US
Inventor
Name:
BACHOVCHIN, William, W.Address:
Cambridge, MA 02142, US
Name:
LAI, Hung-senAddress:
Andover, MA 01810, US
Name:
SANFORD, David, G.Address:
Reading, MA 01867, US
Name:
POPLAWSKI, Sarah, E.Address:
Belmont, MA 02478, US
Name:
WU, WengenAddress:
Medford, MA 02155, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462011989 PDate:
13.6.2014Country:
US
Number:
201462051033 PDate:
16.9.2014Country:
US
Classification
Categories:
A61K 47/54, A61K 47/64, A61K 31/337, A61K 31/4155, A61K 31/4375, A61K 31/4545, A61K 31/517, A61K 31/519, A61K 31/69, A61K 31/704, A61K 31/7068, A61P 29/00, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 24.6.2024
Expires: 14.6.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 18.6.2025
Expires: 14.6.2026
Payer: Árnason Faktor ehf.